HAE 8-K 2026-11-05

HAEMONETICS CORP (HAE) 8-K dated 2026-11-05 — accession 0000313143-26-000150.

HAEMONETICS CORP (HAE) is a medical devices company listed on US.

HAEMONETICS CORP filed a 8-K on 2026-11-05. Accession 0000313143-26-000150.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B.

Not investment advice. The HAE SEC hub lists recent forms. The stock page is the research view.